@article{c61d94a45b794da4a71eb43a288a2b89,
title = "Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq",
abstract = "Pooled CRISPR screens coupled with single-cell RNA-sequencing have enabled systematic interrogation of gene function and regulatory networks. Here, we introduce Cas13 RNA Perturb-seq (CaRPool-seq), which leverages the RNA-targeting CRISPR–Cas13d system and enables efficient combinatorial perturbations alongside multimodal single-cell profiling. CaRPool-seq encodes multiple perturbations on a cleavable CRISPR array that is associated with a detectable barcode sequence, allowing for the simultaneous targeting of multiple genes. We compared CaRPool-seq to existing Cas9-based methods, highlighting its unique strength to efficiently profile combinatorially perturbed cells. Finally, we apply CaRPool-seq to perform multiplexed combinatorial perturbations of myeloid differentiation regulators in an acute myeloid leukemia (AML) model system and identify extensive interactions between different chromatin regulators that can enhance or suppress AML differentiation phenotypes.",
author = "Wessels, {Hans Hermann} and Alejandro M{\'e}ndez-Mancilla and Yuhan Hao and Efthymia Papalexi and Mauck, {William M.} and Lu Lu and Morris, {John A.} and Mimitou, {Eleni P.} and Peter Smibert and Sanjana, {Neville E.} and Rahul Satija",
note = "Funding Information: We thank the Technology Innovation laboratory as well as all members of the Sanjana and Satija laboratories for helpful discussions. We are grateful to Z. Daniloski for cloning the Cas9-effector protein plasmids, to I. Aifantis for advice and helpful discussion related to THP1 experiments, and the Technology Innovation laboratory for generously sharing CITE-seq reagents. N.E.S. and R.S. are supported by New York University and New York Genome Center startup funds. N.E.S. is further supported by DARPA (grant no. D18AP00053), the Brain and Behavior Foundation, the Cancer Research Institute, the National Institutes of Health (NIH)/National Human Genome Research Institute (grant no. DP2HG010099) and the NIH/National Cancer Institute (grant no. R01CA218668). R.S. is supported by the Chan Zuckerberg Initiative (grant nos. EOSS-0000000082 to R.S., HCA-A-1704-01895 to P.S. and R.S.), and the National Institutes of Health (grant nos. DP2HG009623-01 to R.S. and RM1HG011014-01 to P.S. and R.S.). Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.",
year = "2023",
month = jan,
doi = "10.1038/s41592-022-01705-x",
language = "English (US)",
volume = "20",
pages = "86--94",
journal = "Nature methods",
issn = "1548-7091",
publisher = "Public Library of Science",
number = "1",
}